Skip to Content

Raltegravir use while Breastfeeding

Drugs containing Raltegravir: Isentress, Isentress HD, Dutrebis

Medically reviewed by Drugs.com. Last updated on Apr 22, 2020.

Raltegravir Levels and Effects while Breastfeeding

Summary of Use during Lactation

No published information is available on the use of raltegravir during breastfeeding.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Lamivudine, Nelfinavir, Nevirapine, Zidovudine

Substance Identification

Substance Name

Raltegravir

CAS Registry Number

518048-05-0

Drug Class

Breast Feeding

Lactation

Anti-Infective Agents

Anti-HIV Agents

Antiviral Agents

Anti-Retroviral Agents

HIV Integrase Inhibitors

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.